Schwitzer David, Kim Roderick, Williams Fayette, Hammer Daniel
Resident, Department of Oral and Maxillofacial Surgery, Parkland Memorial Hospital, UT Southwestern Medical Center, Dallas, TX.
Director of Research and Assistant Fellowship Director, Division of Maxillofacial Oncology and Reconstructive Surgery, John Peter Smith Hospital, Fort Worth, TX.
J Oral Maxillofac Surg. 2020 Aug;78(8):1334-1342. doi: 10.1016/j.joms.2020.02.003. Epub 2020 Feb 12.
Spindle cell sarcoma (SCS) is a malignancy, with the most recent Surveillance, Epidemiology, and End Results (SEER) data citing a total of 250 reported cases occurring in the head and neck. Of these cases, none originated in the maxillofacial hard tissue. To the best of our knowledge, only 2 cases of primary osseous SCS of the maxillofacial region have been reported. These cases were not accounted for in the SEER data. The diagnosis of SCS requires its differentiation from other sarcomas and spindle cell neoplasms. Therefore, a comprehensive review to reinforce its inclusion in oral and maxillofacial surgeons' differential diagnosis for osseous neoplastic pathology is desired. In the present case report, we have described a maxillary SCS in a patient with an initial diagnosis of a spindle cell lesion of uncertain biologic behavior. We reviewed the data for SCS, including the epidemiologic data, diagnostic challenges, clinical and radiographic presentations, prognostic indicators, and treatment.
梭形细胞肉瘤(SCS)是一种恶性肿瘤,最新的监测、流行病学和最终结果(SEER)数据显示,头颈部共报告了250例病例。在这些病例中,没有一例起源于颌面硬组织。据我们所知,仅报告了2例颌面部原发性骨SCS病例。这些病例未被纳入SEER数据。SCS的诊断需要将其与其他肉瘤和梭形细胞肿瘤相鉴别。因此,需要进行全面综述,以加强其在口腔颌面外科医生对骨肿瘤性病变鉴别诊断中的纳入。在本病例报告中,我们描述了一名最初诊断为生物学行为不确定的梭形细胞病变患者的上颌SCS。我们回顾了SCS的数据,包括流行病学数据、诊断挑战、临床和影像学表现、预后指标以及治疗方法。